William J Waldman

Dynamic medical professional with expertise in procedure assistance and clinical documentation, honed at Dr. Patricia McCormack's Dermatology practice. Demonstrated strong communication skills and adaptability in fast-paced environments, ensuring patient safety and satisfaction. Successfully managed high patient volumes while maintaining HIPAA compliance and enhancing care continuity through effective patient scheduling and team collaboration. Offering detail-oriented approach and commitment to patient care, eager to learn and develop in medical environment. Brings foundational understanding of medical terminology and electronic health records, with readiness to quickly acquire additional knowledge. Ready to use and develop skills in patient interaction.

• Basic Life Support
• CPR and AED
• HIPAA
• CITI
• Biometric and Information Security
• Health Literacy for Public Health Professionals
• Hand Hygiene
• Digital and Social Media

As part of a research project examining the relationship between physical activity and mental health in college students, I helped develop a study proposal investigating how moderate-to-vigorous physical activity (MVPA) may reduce symptoms of anxiety, depression, and stress in undergraduate populations in the United States. The project incorporated a structured 12-week intervention design with planned assessments using validated screening tools such as the Hospital Anxiety and Depression Scale (HADS) and the Depression Anxiety Stress Scale (DASS-21). By outlining participant check-ins, survey timelines, and methods for organizing outcomes into quantitative tables and graphs, I gained experience in research design and the evaluation of behavioral interventions. This work deepened my appreciation for the role of preventive health strategies and reinforced my interest in how lifestyle-based approaches, such as exercise, can support mental well-being and improve overall patient care.

As part of a team-based clinical research project, I evaluated a Phase III randomized, double-blind trial investigating Amenamevir (ASP2151) as an emerging antiviral therapy for herpes zoster compared to the standard treatment, valacyclovir. Through this work, I explored the clinical impact of varicella zoster virus reactivation, particularly in older and immunocompromised populations at higher risk for complications such as postherpetic neuralgia. I analyzed primary outcomes measuring the cessation of new lesion formation within four days, as well as safety data and adverse event profiles across treatment groups. This project strengthened my understanding of antiviral mechanisms, clinical trial design, and the importance of critically assessing efficacy, safety, and accessibility when considering new therapeutic options. Overall, the experience reinforced my interest in evidence-based medicine and the role of research in improving patient care and expanding treatment strategies in clinical practice.